Efinopegdutide vs Oxyntomodulin

Head-to-head comparison of Efinopegdutide (Efinopegdutide (HM12525A), long-acting glucagon-like peptide-1/glucagon receptor dual agonist) and Oxyntomodulin (Endogenous glucagon-like peptide 1 and glucagon co-agonist peptide) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyEfinopegdutideOxyntomodulin
CategoryWeight ManagementWeight Management
Full NameEfinopegdutide (HM12525A), long-acting glucagon-like peptide-1/glucagon receptor dual agonistEndogenous glucagon-like peptide 1 and glucagon co-agonist peptide
Molecular WeightN/A~4,200 Da
Half-LifeApproximately 1 week12-15 minutes
Amino AcidsN/A37
Typical DoseTrial-dependent; weekly SC dosingResearch doses vary; commonly 100-300 mcg in small human studies
RouteSubcutaneousSubcutaneous/IV
Purity≥98%≥98%
Studies Count1480
Research StatusClinicalClinical

Efinopegdutide Benefits

  • reduced body weight
  • improved insulin sensitivity
  • reduced liver fat
  • greater satiety

Oxyntomodulin Benefits

  • reduces appetite
  • increases satiety
  • supports weight loss
  • improves postprandial metabolic signaling

Efinopegdutide Dosing

once-weekly subcutaneous injection|dose escalation during lead-in|maintenance dosing in trials

Oxyntomodulin Dosing

Research-only dosing|Subcutaneous or IV administration in trials|Pair with calorie restriction and monitoring

Efinopegdutide Side Effects

  • nausea
  • decreased appetite
  • fatigue

Oxyntomodulin Side Effects

  • nausea
  • GI discomfort
  • decreased appetite beyond target

Research Overview

Efinopegdutide

Human trials have shown meaningful weight loss and improvements in hepatic steatosis biomarkers. It remains a research compound with ongoing development in metabolic disease.

Oxyntomodulin

Human studies showed acute reductions in food intake and modest weight loss, helping establish the GLP-1 and glucagon co-agonism concept. It remains a foundational peptide for obesity and satiety research.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Efinopegdutide stacks with:

metforminorlistat

Oxyntomodulin stacks with:

calorie-deficitresistance-training
glp1glucagondual-agonistobesitynashGLP-1glucagon-coagonistendogenous-peptideappetite-regulation